Tyro Capital Management LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 13, 2025), Tyro Capital Management LLC reported 10 stock positions worth $269.2 million. Its top holding was Establishment Labs (ESTA) at 16.4% of the portfolio, followed by CRH (CRH, 16.1%) and Cogent Communications Holdin (CCOI, 13.3%). Compared with Q2 2025, it opened 2 new positions, sold out of 2 and added to 8. The biggest buy was a new position in Hinge Health Class A (HNGE) and the biggest sale an exit from Verona Pharma (VRNA).
- Most Recent 13F
- Q2 2026
- Location
- MIAMI, FL
- CIK
- 0001915395
- Portfolio Value
- $269.2M (Q3 2025)
- SEC Filing
- 0001915395-25-000025 ↗ filed Nov 13, 2025
Holdings Value
Holdings 10 stocks · $269.2M
| ESTA Establishment Labs Holdings | 16.41% | 1,077,456 | $44.2M | Add +1.0% |
| CRH CRH PLC | 16.06% | 360,495 | $43.2M | Add +6.8% |
| CCOI Cogent Communications Holdin | 13.32% | 935,287 | $35.9M | Add +46.9% |
| CRS Carpenter Technology | 11.52% | 126,250 | $31.0M | Add +62.5% |
| GRPN Groupon Inc. | 9.46% | 1,091,095 | $25.5M | Add +6.8% |
| CROX Crocs Inc. | 9.00% | 290,008 | $24.2M | Add +60.2% |
| SN Sharkninja Inc. | 8.91% | 232,602 | $24.0M | Add +6.8% |
| ROAD Construction Partners Inc. Class A | 7.76% | 164,488 | $20.9M | Add +6.8% |
| HNGE Hinge Health Inc. Class A | 5.82% | 319,076 | $15.7M | New |
| LENZ Lenz Therapeutics Inc. | 1.74% | 100,672 | $4.7M | New |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
| HNGE Hinge Health Inc. Class A | New | 5.82% | +5.82 |
| CRH CRH PLC | Add +6.8% | 16.06% | +3.90 |
| CRS Carpenter Technology | Add +62.5% | 11.52% | +3.10 |
| CROX Crocs Inc. | Add +60.2% | 9.00% | +1.81 |
| LENZ Lenz Therapeutics Inc. | New | 1.74% | +1.74 |
| ROAD Construction Partners Inc. Class A | Add +6.8% | 7.76% | +1.34 |
| CCOI Cogent Communications Holdin | Add +46.9% | 13.32% | +1.28 |
| SN Sharkninja Inc. | Add +6.8% | 8.91% | +0.46 |
| ESTA Establishment Labs Holdings | Add +1.0% | 16.41% | −1.46 |
| GRPN Groupon Inc. | Add +6.8% | 9.46% | −3.94 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 15 | $445.7M | ESTA, CELH, CRS, SN, SPRY |
| Q1 2026Amended | 23 | $395.0M | ESTA, CRS, CRH, SN, CROX |
| Q4 2025Amended | 11 | $321.3M | ESTA, CRH, SN, CRS, CROX |
| Q3 2025 | 10 | $269.2M | ESTA, CRH, CCOI, CRS, GRPN |
| Q2 2025 | 10 | $254.9M | ESTA, GRPN, CRH, CCOI, SN |
| Q1 2025 | 14 | $268.4M | ESTA, CRS, CCOI, CRH, ROIV |
| Q4 2024 | 11 | $233.8M | CCOI, GPGI, CRS, CRH, ROIV |
| Q3 2024Amended | 12 | $194.6M | CCOI, CRS, CRH, ROIV, GPGI |
| Q2 2024 | 18 | $220.6M | HWM, CROX, CCOI, ROIV, CRH |
| Q1 2024 | 16 | $173.1M | CRH, CROX, HWM, CCOI, ROAD |